Latest News about NVS
Recent news which mentions NVS
From Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
July 03, 2023
From Benzinga
From Motley Fool
From MarketWatch
From Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
June 30, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 29, 2023
From Benzinga
From Benzinga
7 Top Growth Stocks to Watch for H2 2023
June 29, 2023
From InvestorPlace
From Benzinga
From Benzinga
Why Shares of Vera Therapeutics Jumped Tuesday
June 20, 2023
From Motley Fool
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions
June 19, 2023
From Motley Fool
From Benzinga
Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating
June 14, 2023
From Benzinga
From InvestorPlace
Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say
June 12, 2023
From MarketWatch
From Benzinga
From Motley Fool
From Benzinga
Why Is Chinook Therapeutics (KDNY) Stock Up 58% Today?
June 12, 2023
From InvestorPlace
From InvestorPlace
Why Are Chinook Therapeutics Shares Trading Higher Today
June 12, 2023
From Benzinga
From Benzinga
Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
June 12, 2023
From MarketWatch
From MarketWatch
From Benzinga
Novartis' Sandoz Foresees Rapid Growth Post Spin-Off in Generics Market Amid Upcoming Patent Expirations
June 08, 2023
Tickers
NVS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.